One-Cycle BE500P Seems Safe for High-Risk Early Testicular Cancer
Malignant recurrence rate was 1.3 percent at two years for one-cycle BE500P in high-risk early-stage disease
More Education Needed on Breast Density and Screening Choices
Women largely do not know breast density ups risk for breast cancer even in U.S. states with notification
Price Hikes for Hundreds of Medications
Prices of 411 drugs have increased an average of 5 percent
Laser-Based Imaging + AI May Diagnose Brain Tumors in OR
Accurate diagnosis in <150 seconds in the operating room could improve decision-making during surgery
Adverse Events Decreased With Proton Chemoradiotherapy
Relative risks lower for 90-day adverse events of at least grade 3 and 2 compared with photon therapy
3-D Tattoo Device Aids With Nipple Reconstruction
New device expands accessibility of technique to plastic surgeons as an in-office procedure
Routine HPV Testing May Be Warranted for Sinonasal Cancers
HPV-positive sinonasal squamous cell carcinoma associated with improved overall survival
Patient Experiences Modestly Worse After Hospital Acquisition
No significant differential changes found in 30-day readmission rates or 30-day mortality
December 2019 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for December 2019. This roundup includes...
Survivors of Childhood Cancers at Risk for Shortened Life Span
Greatest gaps in life expectancy seen for those receiving radiotherapy, alone or combined with chemo
